Compositions and methods including a recombinant human MAB that promotes CNS remyelination

Details for Australian Patent Application No. 2010202111 (hide)

Owner Acorda Therapeutics Mayo Foundation for Medical Education & Research

Inventors Rodriguez, Moses; Gruskin, Elliot A.; Chojnicki, Eric; Warrington, Arthur E.; Bieber, Allan J.

Agent Madderns

Pub. Number AU-A-2010202111

Parent 2004247021

Filing date 25 May 2010

Wipo publication date 17 June 2010

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/573 (2006.01)

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

10 June 2010 Complete Application Filed

17 June 2010 Application Open to Public Inspection

  Published as AU-A-2010202111

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010202112-Analysis instrument for processing a microfluidic device

2010202110-Efficient signaling over access channel